FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

9467411000001108: Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
135871000001111 Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
135881000001113 Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
30980501000001112 Lysodren 500mg tablets (Laboratoire HRA Pharma) 100 tablet (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
30980601000001111 Lysodren 500mg tablets (Laboratoire HRA Pharma) 100 tablet en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
56849801000001117 Lysodren 500mg tablets (HRA Pharma UK Ltd) 100 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet Is a Mitotane 500mg tablets 100 tablet true Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet Is pack of Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) false Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet Has active ingredient Mitotane false Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet Has AMP Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) true Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet Has specific active ingredient Mitotane true Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lysodren 500mg tablets (HRA Pharma UK & Ireland Ltd) 100 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start